Modeling tumor progression by the sequential introduction of genetic alterations into the genome of human normal cells.
about
RAS Synthetic Lethal Screens Revisited: Still Seeking the Elusive Prize?The stress phenotype makes cancer cells addicted to CDT2, a substrate receptor of the CRL4 ubiquitin ligase.The c.*229C > T gene polymorphism in 3'UTR region of the topoisomerase IIβ binding protein 1 gene and LOH in BRCA1/2 regions and their effect on the risk and progression of human laryngeal carcinoma.
P2860
Modeling tumor progression by the sequential introduction of genetic alterations into the genome of human normal cells.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Modeling tumor progression by ...... genome of human normal cells.
@en
Modeling tumor progression by ...... genome of human normal cells.
@nl
type
label
Modeling tumor progression by ...... genome of human normal cells.
@en
Modeling tumor progression by ...... genome of human normal cells.
@nl
prefLabel
Modeling tumor progression by ...... genome of human normal cells.
@en
Modeling tumor progression by ...... genome of human normal cells.
@nl
P2860
P50
P356
P1433
P1476
Modeling tumor progression by ...... e genome of human normal cells
@en
P2093
Alberto Pisacane
Davide Zecchin
P2860
P304
P356
10.1002/HUMU.22234
P577
2013-01-04T00:00:00Z